Maxidex is a Ophthalmic Suspension in the Human Prescription Drug category. It is labeled and distributed by Alcon Laboratories, Inc.. The primary component is Dexamethasone.
Product ID | 0998-0615_52cf7e89-eadd-4dc4-b1d5-8a36e2dc237c |
NDC | 0998-0615 |
Product Type | Human Prescription Drug |
Proprietary Name | Maxidex |
Generic Name | Dexamethasone |
Dosage Form | Suspension |
Route of Administration | OPHTHALMIC |
Marketing Start Date | 1966-05-15 |
Marketing Category | NDA / NDA |
Application Number | NDA013422 |
Labeler Name | Alcon Laboratories, Inc. |
Substance Name | DEXAMETHASONE |
Active Ingredient Strength | 1 mg/mL |
Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 1966-05-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA013422 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 1966-05-15 |
Ingredient | Strength |
---|---|
DEXAMETHASONE | 1 mg/mL |
SPL SET ID: | ecd69437-dd1a-453b-991d-5c5f277a3abd |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0998-0615 | Maxidex | Maxidex |
0054-3177 | Dexamethasone | Dexamethasone |
0054-4179 | Dexamethasone | Dexamethasone |
0054-4180 | Dexamethasone | Dexamethasone |
0054-4181 | Dexamethasone | Dexamethasone |
0054-4182 | Dexamethasone | Dexamethasone |
0054-4183 | Dexamethasone | Dexamethasone |
0054-4184 | Dexamethasone | Dexamethasone |
0054-4186 | Dexamethasone | Dexamethasone |
0054-8174 | Dexamethasone | Dexamethasone |
0023-3348 | OZURDEX | dexamethasone |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
MAXIDEX 90274189 not registered Live/Pending |
ATG Ceylon (Pvt) Limited 2020-10-23 |
MAXIDEX 85164978 not registered Dead/Abandoned |
ATG Ceylon (PVT) Limited 2010-10-29 |
MAXIDEX 72150144 0750424 Live/Registered |
Alcon Laboratories, Inc. 1962-07-31 |